SlideShare una empresa de Scribd logo
1 de 15
Descargar para leer sin conexión
Tempo Assist
4Q09 Earnings Release
Operating Highlights


• The year of 2009 was important for the Company with investments in systems
(proprietary dental platform), noticeable development in processes (specially to
grant integration of the acquired companies in order to optimize synergies), strategic
planning and team reinforcement (new management);

• SAP Go live on January, 2010. Health and Assistance segments are implemented in
SAP. Dental segment will be implemented during the first half of the year;

• New brand in 2010: Tempo Participações is now Tempo Assist;

• ANS approval of the Unibanco Saúde acquisition. The agreement was made in
2009. With the approval, the insurance company results will be incorporated into
Tempo’s from the second quarter 2010 onwards.
Market Segments and its
Perspectives
  Dental Plans               Health             Health Insurance         Specialized
                           Management                                    Assistances

  Ranking: #3           Ranking: #1              Ranking: n/a           Assistances 24h
  854k lives            1.58 million of lives    70klives               Ranking: #1
  Market: B2B and       Market: B2B;             Market: B2B;           15 millions items
  B2B2C;                insurances and HMO’s     small to medium size   Mercado: B2B and
  Clients: corporate,   public entities and      corporate clients      B2B2C; insurances
  affinity channels     corporate clients




                                  Promising Perspectives



   Affinity
                           Stop Loss                SME                 End users
  Channels
Tempo Consolidated




 Health Segment: 15% growth in beneficiaries, reaching a total of 1.6 million lives, and strong
 expansion in homecare division;


 Dental Segment: growth driven by the annualization of past acquisitions and establishment of new
 partnerships to distribute dental insurance;


 Assistances Segment: added Itaú-Unibanco’s personal & residence assistance account, a large number of
 covered items;
                                                                                                    4
SG&A (BU’s) – R$ Million


                                                                          177,0
    166,2                                                     29,4
                                     4,8                                             non
                  -6,1                                                    39,5    recurring
    31,9
                            -16,5               -0,7
                                      +2%

    134,3                                                                137,5    recurring
                                                                                    SG&A




2008 BUs SG&A   Personnel   G&A     Sales   Taxes and fees   Others   2009 BUs SG&A




                                                                                          5
SG&A (Holding)


                                11,0                   0,2
                                        -0,01                                    28,9
                                                                    -3,9                     non
                                                                                  2,1     recurring
                     10,6


                                        +141%                                     26,8
      11,1                                                                                recurring
                                                                                            SG&A




2008 Holding SG&A   Personnel   G&A    Marketing   Taxes and fees   Other   2009 Holding SG&A




                                                                                                      6
Recurring Operating Result



                    2008                        2009



                                          34%          38%
              43%          41%

                     16%                    29%




                     Health      Dental          Assistance




                                                              7
R$Million                                          2008       2009     Var.%
Net Revenues                                         425.3     448.5      5.5%
Cost of Rendered Services                           (332.7)   (353.2)    -6.2%
Gross Profit                                          92.6      95.3      2.9%
Gross Margin (%)                                     21.8%     21.3% - 0.5 p.p.
Selling, General and Administrative Expenses         (77.8)    (86.4) -11.0%
Operating Results                                     14.8       8.9   -39.8%
(+)Non recurring Adjusts                             (16.9)    (25.1) -48.3%
Recurring Operating Results                           31.7      34.0      7.2%
Operating Margin (%)                                  7.5%      7.6% 0.1 p.p.


 Beneficiaries: 14.6% growth when comparing with same period in 2008.

General and Administrative Expenses: impacted due to the allowance for doubtful accounts of R$ 22.7
millions;

  Recurring Operating Result: 7.2% growth when comparing with the previous year.



                                               Press Release 4T09                            8
Beneficiaries (million)                           Net Revenues (R$ million)
                                           14.6%

                                                                            5.5%


 1.38     1.39      1.38          1.34    1.58                                      448.5
                                                               425.3




4Q08    1Q09       2Q09          3Q09    4Q09                 2008                 2009




Cost of Services Rendered (R$ million) and         Recurring Operating Results (R$ million) and
             Loss Ratio (%)                                      Margin (%)
                                                                                            7.6%
                                                                      7.5%

                   6.2%                                                            7.2%


                          353.2                                                            34.0
           332.7                                                      31.7



                                                                                                   9
          2008            2009                                       2008                 2009
R$Million                                          2008         2009   Var.%
   Net Revenues                                            56.1     99.7   77.8%
   Cost of Rendered Services                              (27.4)   (45.1) -64.5%
   Loss Ratio                                               47%      44% -3.4 p.p.
   Gross Profit                                            28.6     54.6   90.7%
   Gross Margin (%)                                       51.1%    54.8% 3.7 p.p.
   Selling, General and Administrative Expenses           (20.9)   (30.9) -47.5%
   Operating Results                                        7.7     23.7 208.0%
   (+)Non recurring Adjusts                                (4.5)    (2.3)    0.0%
   Recurring Operating Results                             12.2     26.0 112.9%
   Operating Margin (%)                                   21.8%    26.1% 4.3 p.p.



Beneficiaries: 2% growth in the total numbers of lives;

Loss ratio: Loss ratio in 2009 decreased 4.7 p.p. when compared to 2008, ending 2009 with 44%;

Recurring operating result:112.9% growth when comparing to the previous year, reaching 26 millions.
Beneficiaries (‘000)                                 Net Revenues (R$ million)

                                                  2.6%                    77.8%


                        879                                                        99.7
      833      849                   851     854                  56.1



    4Q08     1Q09     2Q09      3Q09       4Q09
                                                                 2008             2009




Cost of Services Rendered (R$ million) and               Recurring Operating Results (R$ million) and
             Loss Ratio (%)                                            Margin (%)
               47%                                                      47%
                              44%                                                     44%

                      64.5%                                                   64.5%

                               45.1                                                      45.1
               27.4                                                  27.4


             2008             2009                                 2008               2009              11
R$Million                                         2008     2009     Var.%
    Net Revenues                                       238.2 190.8    -19.9%
    Cost of Rendered Services                         (148.2) (112.8)  23.8%
    Loss Ratio                                         55.9% 53.3% - 2.6 p.p.
    Gross Profit                                        90.0    78.0  -13.4%
    Gross Margin (%)                                     38%     41% 3.1 p.p.
    Selling, General and Administrative Expenses       (67.4) (59.7)   11.4%
    Operating Results                                   22.6    18.2  -19.3%
    (+)Non recurring Adjusts                           (10.5) (12.2) -16.2%
    Recurring Operating Results                         33.1    30.4   -8.0%
    Operating Margin (%)                               13.9% 15.9% 2.1 p.p.

Insured Items: 15 million items, representing a 9.6% reduction year over year due to a loss of an important
client at the end of 2008.

Loss Ratio: The loss ratio presented a 3.2pp reduction year on year, reaching 53.3% in 2009;

General and Administrative Expenses: 11.4% reduction when comparing to 2008. impacted due to the
allowance for doubtful accounts of R$ 3.5 millions;

 Recurring Operating Result: the revenues reduction impacted the BUs operating result, which posted a
8% reduction, however there was an increase in operating margin of 2.1pp.
Insured Items (in millions)                                        Net Revenues (R$ million)
million    4Q08         1Q09            2Q09      3Q09    4Q09
                                                                                           19.9%
Itens       16.55       12.17           12.99     13.78   15.00



                                                                                 238.2
                                                                                                 190.8
                                13%


                                        21%
                       65%
                                                                                2008         2009




   Cost of Services Rendered (R$ million) and                     Recurring Operating Results (R$ million) and
                Loss Ratio (%)                                                  Margin (%)
                55.9%                                                                            15.9%
                                          53.3%                                   13.9%
                                -23.8                                                    -8.0%

                    148.2           112.8
                                                                                33.1             30.4


                2008              2009                                                                           13
                                                                               2008          2009
Capex
Capex (R$ million)       1Q09     2Q09     3Q09     4Q09      2009
Software                    1.6      2.3      1.1       2.6     7.7
IT Equipments               0.2      0.2      0.6       1.2     2.2
Buildings                   -        0.0      0.2       0.5     0.7
Furniture & Equipment       -        -        0.0       0.1     0.1
Other                       -        0.0      0.5         0     0.5
Total                       1.8      2.6      2.4       4.4    11.2


  In 2009, the company invested a total amount of R$ 11.2 million, mainly directed to
the development of IT solutions (software), specially in the implementation of SAP and
the development of the operational platform of the dental plans segment (Odonto
Utilis).
New Management



                                                             Since April, 2009




                                               BUs
      Since IPO               Since December, 2009   Since IPO                      Since June, 2009




  Since November, 2009
                                     Corporate Structure
                         Since July, 2009                        Since July, 2009       Since February, 2010

Más contenido relacionado

La actualidad más candente

metlife Investor Day 2008 International
metlife Investor Day 2008 Internationalmetlife Investor Day 2008 International
metlife Investor Day 2008 Internationalfinance5
 
1Q11 Earnings Release Presentation
1Q11 Earnings Release Presentation1Q11 Earnings Release Presentation
1Q11 Earnings Release Presentationbrproperties
 
omnicom group Q1 2006 Investor Presentation
omnicom group  Q1 2006 Investor Presentationomnicom group  Q1 2006 Investor Presentation
omnicom group Q1 2006 Investor Presentationfinance22
 
omnicom group Q1 2005 Investor Presentation
omnicom group  Q1 2005 Investor Presentationomnicom group  Q1 2005 Investor Presentation
omnicom group Q1 2005 Investor Presentationfinance22
 
Generali Group 1 Q 2008 Results
Generali Group 1 Q 2008 ResultsGenerali Group 1 Q 2008 Results
Generali Group 1 Q 2008 ResultsGenerali
 
Honeywell Barclays Capital Industrial Select Conference Presentation
Honeywell 	 Barclays Capital Industrial Select Conference PresentationHoneywell 	 Barclays Capital Industrial Select Conference Presentation
Honeywell Barclays Capital Industrial Select Conference Presentationfinance8
 
RYDERFINAL Q107
RYDERFINAL Q107RYDERFINAL Q107
RYDERFINAL Q107finance44
 
Generali Group 1Q 2009 Results
Generali Group 1Q 2009 ResultsGenerali Group 1Q 2009 Results
Generali Group 1Q 2009 ResultsGenerali
 
northrop grumman Slide Presentation 2008 1st
northrop grumman Slide Presentation 2008 1stnorthrop grumman Slide Presentation 2008 1st
northrop grumman Slide Presentation 2008 1stfinance8
 
Q1 2009 Earning Report of Affiliated Computer Services
Q1 2009 Earning Report of Affiliated Computer Services Q1 2009 Earning Report of Affiliated Computer Services
Q1 2009 Earning Report of Affiliated Computer Services earningreport earningreport
 
Tim Presentation Deutsche Conference Set09 Eng
Tim Presentation Deutsche Conference Set09 EngTim Presentation Deutsche Conference Set09 Eng
Tim Presentation Deutsche Conference Set09 EngTIM RI
 
1 Q09 Earnings Eng Final[20090421134102809]
1 Q09 Earnings Eng Final[20090421134102809]1 Q09 Earnings Eng Final[20090421134102809]
1 Q09 Earnings Eng Final[20090421134102809]Sang Park
 
Q1 2008 Comcast Corporation Earnings Conference Call
	Q1 2008 Comcast Corporation Earnings Conference Call	Q1 2008 Comcast Corporation Earnings Conference Call
Q1 2008 Comcast Corporation Earnings Conference Callfinance8
 
Earnings Release 3Q09 Presentation
Earnings Release 3Q09 PresentationEarnings Release 3Q09 Presentation
Earnings Release 3Q09 PresentationProfarma
 

La actualidad más candente (16)

metlife Investor Day 2008 International
metlife Investor Day 2008 Internationalmetlife Investor Day 2008 International
metlife Investor Day 2008 International
 
1Q11 Earnings Release Presentation
1Q11 Earnings Release Presentation1Q11 Earnings Release Presentation
1Q11 Earnings Release Presentation
 
Apresentação resultados eng 1 t10.final
Apresentação resultados eng 1 t10.finalApresentação resultados eng 1 t10.final
Apresentação resultados eng 1 t10.final
 
omnicom group Q1 2006 Investor Presentation
omnicom group  Q1 2006 Investor Presentationomnicom group  Q1 2006 Investor Presentation
omnicom group Q1 2006 Investor Presentation
 
omnicom group Q1 2005 Investor Presentation
omnicom group  Q1 2005 Investor Presentationomnicom group  Q1 2005 Investor Presentation
omnicom group Q1 2005 Investor Presentation
 
Generali Group 1 Q 2008 Results
Generali Group 1 Q 2008 ResultsGenerali Group 1 Q 2008 Results
Generali Group 1 Q 2008 Results
 
Honeywell Barclays Capital Industrial Select Conference Presentation
Honeywell 	 Barclays Capital Industrial Select Conference PresentationHoneywell 	 Barclays Capital Industrial Select Conference Presentation
Honeywell Barclays Capital Industrial Select Conference Presentation
 
RYDERFINAL Q107
RYDERFINAL Q107RYDERFINAL Q107
RYDERFINAL Q107
 
Generali Group 1Q 2009 Results
Generali Group 1Q 2009 ResultsGenerali Group 1Q 2009 Results
Generali Group 1Q 2009 Results
 
Q2 2012 Financial Highlights
Q2 2012 Financial HighlightsQ2 2012 Financial Highlights
Q2 2012 Financial Highlights
 
northrop grumman Slide Presentation 2008 1st
northrop grumman Slide Presentation 2008 1stnorthrop grumman Slide Presentation 2008 1st
northrop grumman Slide Presentation 2008 1st
 
Q1 2009 Earning Report of Affiliated Computer Services
Q1 2009 Earning Report of Affiliated Computer Services Q1 2009 Earning Report of Affiliated Computer Services
Q1 2009 Earning Report of Affiliated Computer Services
 
Tim Presentation Deutsche Conference Set09 Eng
Tim Presentation Deutsche Conference Set09 EngTim Presentation Deutsche Conference Set09 Eng
Tim Presentation Deutsche Conference Set09 Eng
 
1 Q09 Earnings Eng Final[20090421134102809]
1 Q09 Earnings Eng Final[20090421134102809]1 Q09 Earnings Eng Final[20090421134102809]
1 Q09 Earnings Eng Final[20090421134102809]
 
Q1 2008 Comcast Corporation Earnings Conference Call
	Q1 2008 Comcast Corporation Earnings Conference Call	Q1 2008 Comcast Corporation Earnings Conference Call
Q1 2008 Comcast Corporation Earnings Conference Call
 
Earnings Release 3Q09 Presentation
Earnings Release 3Q09 PresentationEarnings Release 3Q09 Presentation
Earnings Release 3Q09 Presentation
 

Destacado

Valuing "value-add" services received from Law Firms
Valuing "value-add" services received from Law FirmsValuing "value-add" services received from Law Firms
Valuing "value-add" services received from Law Firmsmatthewwhalley
 
MHR What is a PEO and an ASO
MHR What is a PEO and an ASOMHR What is a PEO and an ASO
MHR What is a PEO and an ASOdonaldmartin
 
HR Fractional HR Services for the Mid-Market Report
HR Fractional HR Services for the Mid-Market ReportHR Fractional HR Services for the Mid-Market Report
HR Fractional HR Services for the Mid-Market ReportCharles Bedard
 
Clinical Co-Management Arrangements: Trends, Issues and FMV Considerations
Clinical Co-Management Arrangements: Trends, Issues and FMV ConsiderationsClinical Co-Management Arrangements: Trends, Issues and FMV Considerations
Clinical Co-Management Arrangements: Trends, Issues and FMV ConsiderationsCBIZ, Inc.
 
Sample management agreement & basic terms
Sample management agreement & basic termsSample management agreement & basic terms
Sample management agreement & basic termsherproperty
 
MSO Program Overview
MSO Program OverviewMSO Program Overview
MSO Program OverviewCRISP
 
Valuing Healthcare Management Services Agreements
Valuing Healthcare Management Services AgreementsValuing Healthcare Management Services Agreements
Valuing Healthcare Management Services AgreementsPYA, P.C.
 

Destacado (7)

Valuing "value-add" services received from Law Firms
Valuing "value-add" services received from Law FirmsValuing "value-add" services received from Law Firms
Valuing "value-add" services received from Law Firms
 
MHR What is a PEO and an ASO
MHR What is a PEO and an ASOMHR What is a PEO and an ASO
MHR What is a PEO and an ASO
 
HR Fractional HR Services for the Mid-Market Report
HR Fractional HR Services for the Mid-Market ReportHR Fractional HR Services for the Mid-Market Report
HR Fractional HR Services for the Mid-Market Report
 
Clinical Co-Management Arrangements: Trends, Issues and FMV Considerations
Clinical Co-Management Arrangements: Trends, Issues and FMV ConsiderationsClinical Co-Management Arrangements: Trends, Issues and FMV Considerations
Clinical Co-Management Arrangements: Trends, Issues and FMV Considerations
 
Sample management agreement & basic terms
Sample management agreement & basic termsSample management agreement & basic terms
Sample management agreement & basic terms
 
MSO Program Overview
MSO Program OverviewMSO Program Overview
MSO Program Overview
 
Valuing Healthcare Management Services Agreements
Valuing Healthcare Management Services AgreementsValuing Healthcare Management Services Agreements
Valuing Healthcare Management Services Agreements
 

Similar a Conference Call Presentation 4Q09

Earnings Release 1Q09 Presentation
Earnings Release 1Q09 PresentationEarnings Release 1Q09 Presentation
Earnings Release 1Q09 PresentationProfarma
 
2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation2Q08Results Conference Call Presentation
2Q08Results Conference Call PresentationTempo Participações
 
2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation2Q08Results Conference Call Presentation
2Q08Results Conference Call PresentationTempo Participações
 
Earnings Release 1Q08 Presentation
Earnings Release 1Q08 PresentationEarnings Release 1Q08 Presentation
Earnings Release 1Q08 PresentationProfarma
 
Earnings Release 2Q08 Presentation
Earnings Release 2Q08 PresentationEarnings Release 2Q08 Presentation
Earnings Release 2Q08 PresentationProfarma
 
Earnings Release 2Q08 Presentation
Earnings Release 2Q08 PresentationEarnings Release 2Q08 Presentation
Earnings Release 2Q08 PresentationProfarma
 
Earnings Release 2Q08 Presentation
Earnings Release 2Q08 PresentationEarnings Release 2Q08 Presentation
Earnings Release 2Q08 PresentationProfarma
 
Earnings Release 3Q07 Presentation
Earnings Release 3Q07 PresentationEarnings Release 3Q07 Presentation
Earnings Release 3Q07 PresentationProfarma
 
Earnings Release 3 Q08
Earnings Release 3 Q08Earnings Release 3 Q08
Earnings Release 3 Q08Profarma
 
Earnings Release 3Q08 Presentation
Earnings Release 3Q08 PresentationEarnings Release 3Q08 Presentation
Earnings Release 3Q08 PresentationProfarma
 
Earnings Release 4 Q07
Earnings Release 4 Q07Earnings Release 4 Q07
Earnings Release 4 Q07Profarma
 
Earnings Release 4Q07 Presentation
Earnings Release 4Q07 PresentationEarnings Release 4Q07 Presentation
Earnings Release 4Q07 PresentationProfarma
 
Profarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 EngProfarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 Engprofarma1
 
arnings Release 2Q07 Presentation
arnings Release 2Q07 Presentationarnings Release 2Q07 Presentation
arnings Release 2Q07 PresentationProfarma
 
Earnings Release 2 Q07
Earnings Release 2 Q07Earnings Release 2 Q07
Earnings Release 2 Q07Profarma
 
Profarma 4Q10
Profarma 4Q10Profarma 4Q10
Profarma 4Q10Profarma
 
Profarma 4Q10
Profarma 4Q10Profarma 4Q10
Profarma 4Q10Profarma
 
3Q 2011 Results Conference Call
3Q 2011 Results Conference Call 3Q 2011 Results Conference Call
3Q 2011 Results Conference Call WEG
 

Similar a Conference Call Presentation 4Q09 (20)

Earnings Release 1Q09 Presentation
Earnings Release 1Q09 PresentationEarnings Release 1Q09 Presentation
Earnings Release 1Q09 Presentation
 
2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation
 
2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation
 
Earnings Release 1Q08 Presentation
Earnings Release 1Q08 PresentationEarnings Release 1Q08 Presentation
Earnings Release 1Q08 Presentation
 
Earnings Release 2Q08 Presentation
Earnings Release 2Q08 PresentationEarnings Release 2Q08 Presentation
Earnings Release 2Q08 Presentation
 
Earnings Release 2Q08 Presentation
Earnings Release 2Q08 PresentationEarnings Release 2Q08 Presentation
Earnings Release 2Q08 Presentation
 
Earnings Release 2Q08 Presentation
Earnings Release 2Q08 PresentationEarnings Release 2Q08 Presentation
Earnings Release 2Q08 Presentation
 
Earnings Release 3Q07 Presentation
Earnings Release 3Q07 PresentationEarnings Release 3Q07 Presentation
Earnings Release 3Q07 Presentation
 
Earnings Release 3 Q08
Earnings Release 3 Q08Earnings Release 3 Q08
Earnings Release 3 Q08
 
Earnings Release 3Q08 Presentation
Earnings Release 3Q08 PresentationEarnings Release 3Q08 Presentation
Earnings Release 3Q08 Presentation
 
Earnings Release 4 Q07
Earnings Release 4 Q07Earnings Release 4 Q07
Earnings Release 4 Q07
 
Earnings Release 4Q07 Presentation
Earnings Release 4Q07 PresentationEarnings Release 4Q07 Presentation
Earnings Release 4Q07 Presentation
 
Profarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 EngProfarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 Eng
 
3Q08 Earnings Release Presentation
3Q08 Earnings Release Presentation3Q08 Earnings Release Presentation
3Q08 Earnings Release Presentation
 
3Q08 Earnings Release Presentation
3Q08 Earnings Release Presentation3Q08 Earnings Release Presentation
3Q08 Earnings Release Presentation
 
arnings Release 2Q07 Presentation
arnings Release 2Q07 Presentationarnings Release 2Q07 Presentation
arnings Release 2Q07 Presentation
 
Earnings Release 2 Q07
Earnings Release 2 Q07Earnings Release 2 Q07
Earnings Release 2 Q07
 
Profarma 4Q10
Profarma 4Q10Profarma 4Q10
Profarma 4Q10
 
Profarma 4Q10
Profarma 4Q10Profarma 4Q10
Profarma 4Q10
 
3Q 2011 Results Conference Call
3Q 2011 Results Conference Call 3Q 2011 Results Conference Call
3Q 2011 Results Conference Call
 

Conference Call Presentation 4Q09

  • 2. Operating Highlights • The year of 2009 was important for the Company with investments in systems (proprietary dental platform), noticeable development in processes (specially to grant integration of the acquired companies in order to optimize synergies), strategic planning and team reinforcement (new management); • SAP Go live on January, 2010. Health and Assistance segments are implemented in SAP. Dental segment will be implemented during the first half of the year; • New brand in 2010: Tempo Participações is now Tempo Assist; • ANS approval of the Unibanco Saúde acquisition. The agreement was made in 2009. With the approval, the insurance company results will be incorporated into Tempo’s from the second quarter 2010 onwards.
  • 3. Market Segments and its Perspectives Dental Plans Health Health Insurance Specialized Management Assistances Ranking: #3 Ranking: #1 Ranking: n/a Assistances 24h 854k lives 1.58 million of lives 70klives Ranking: #1 Market: B2B and Market: B2B; Market: B2B; 15 millions items B2B2C; insurances and HMO’s small to medium size Mercado: B2B and Clients: corporate, public entities and corporate clients B2B2C; insurances affinity channels corporate clients Promising Perspectives Affinity Stop Loss SME End users Channels
  • 4. Tempo Consolidated Health Segment: 15% growth in beneficiaries, reaching a total of 1.6 million lives, and strong expansion in homecare division; Dental Segment: growth driven by the annualization of past acquisitions and establishment of new partnerships to distribute dental insurance; Assistances Segment: added Itaú-Unibanco’s personal & residence assistance account, a large number of covered items; 4
  • 5. SG&A (BU’s) – R$ Million 177,0 166,2 29,4 4,8 non -6,1 39,5 recurring 31,9 -16,5 -0,7 +2% 134,3 137,5 recurring SG&A 2008 BUs SG&A Personnel G&A Sales Taxes and fees Others 2009 BUs SG&A 5
  • 6. SG&A (Holding) 11,0 0,2 -0,01 28,9 -3,9 non 2,1 recurring 10,6 +141% 26,8 11,1 recurring SG&A 2008 Holding SG&A Personnel G&A Marketing Taxes and fees Other 2009 Holding SG&A 6
  • 7. Recurring Operating Result 2008 2009 34% 38% 43% 41% 16% 29% Health Dental Assistance 7
  • 8. R$Million 2008 2009 Var.% Net Revenues 425.3 448.5 5.5% Cost of Rendered Services (332.7) (353.2) -6.2% Gross Profit 92.6 95.3 2.9% Gross Margin (%) 21.8% 21.3% - 0.5 p.p. Selling, General and Administrative Expenses (77.8) (86.4) -11.0% Operating Results 14.8 8.9 -39.8% (+)Non recurring Adjusts (16.9) (25.1) -48.3% Recurring Operating Results 31.7 34.0 7.2% Operating Margin (%) 7.5% 7.6% 0.1 p.p. Beneficiaries: 14.6% growth when comparing with same period in 2008. General and Administrative Expenses: impacted due to the allowance for doubtful accounts of R$ 22.7 millions; Recurring Operating Result: 7.2% growth when comparing with the previous year. Press Release 4T09 8
  • 9. Beneficiaries (million) Net Revenues (R$ million) 14.6% 5.5% 1.38 1.39 1.38 1.34 1.58 448.5 425.3 4Q08 1Q09 2Q09 3Q09 4Q09 2008 2009 Cost of Services Rendered (R$ million) and Recurring Operating Results (R$ million) and Loss Ratio (%) Margin (%) 7.6% 7.5% 6.2% 7.2% 353.2 34.0 332.7 31.7 9 2008 2009 2008 2009
  • 10. R$Million 2008 2009 Var.% Net Revenues 56.1 99.7 77.8% Cost of Rendered Services (27.4) (45.1) -64.5% Loss Ratio 47% 44% -3.4 p.p. Gross Profit 28.6 54.6 90.7% Gross Margin (%) 51.1% 54.8% 3.7 p.p. Selling, General and Administrative Expenses (20.9) (30.9) -47.5% Operating Results 7.7 23.7 208.0% (+)Non recurring Adjusts (4.5) (2.3) 0.0% Recurring Operating Results 12.2 26.0 112.9% Operating Margin (%) 21.8% 26.1% 4.3 p.p. Beneficiaries: 2% growth in the total numbers of lives; Loss ratio: Loss ratio in 2009 decreased 4.7 p.p. when compared to 2008, ending 2009 with 44%; Recurring operating result:112.9% growth when comparing to the previous year, reaching 26 millions.
  • 11. Beneficiaries (‘000) Net Revenues (R$ million) 2.6% 77.8% 879 99.7 833 849 851 854 56.1 4Q08 1Q09 2Q09 3Q09 4Q09 2008 2009 Cost of Services Rendered (R$ million) and Recurring Operating Results (R$ million) and Loss Ratio (%) Margin (%) 47% 47% 44% 44% 64.5% 64.5% 45.1 45.1 27.4 27.4 2008 2009 2008 2009 11
  • 12. R$Million 2008 2009 Var.% Net Revenues 238.2 190.8 -19.9% Cost of Rendered Services (148.2) (112.8) 23.8% Loss Ratio 55.9% 53.3% - 2.6 p.p. Gross Profit 90.0 78.0 -13.4% Gross Margin (%) 38% 41% 3.1 p.p. Selling, General and Administrative Expenses (67.4) (59.7) 11.4% Operating Results 22.6 18.2 -19.3% (+)Non recurring Adjusts (10.5) (12.2) -16.2% Recurring Operating Results 33.1 30.4 -8.0% Operating Margin (%) 13.9% 15.9% 2.1 p.p. Insured Items: 15 million items, representing a 9.6% reduction year over year due to a loss of an important client at the end of 2008. Loss Ratio: The loss ratio presented a 3.2pp reduction year on year, reaching 53.3% in 2009; General and Administrative Expenses: 11.4% reduction when comparing to 2008. impacted due to the allowance for doubtful accounts of R$ 3.5 millions; Recurring Operating Result: the revenues reduction impacted the BUs operating result, which posted a 8% reduction, however there was an increase in operating margin of 2.1pp.
  • 13. Insured Items (in millions) Net Revenues (R$ million) million 4Q08 1Q09 2Q09 3Q09 4Q09 19.9% Itens 16.55 12.17 12.99 13.78 15.00 238.2 190.8 13% 21% 65% 2008 2009 Cost of Services Rendered (R$ million) and Recurring Operating Results (R$ million) and Loss Ratio (%) Margin (%) 55.9% 15.9% 53.3% 13.9% -23.8 -8.0% 148.2 112.8 33.1 30.4 2008 2009 13 2008 2009
  • 14. Capex Capex (R$ million) 1Q09 2Q09 3Q09 4Q09 2009 Software 1.6 2.3 1.1 2.6 7.7 IT Equipments 0.2 0.2 0.6 1.2 2.2 Buildings - 0.0 0.2 0.5 0.7 Furniture & Equipment - - 0.0 0.1 0.1 Other - 0.0 0.5 0 0.5 Total 1.8 2.6 2.4 4.4 11.2 In 2009, the company invested a total amount of R$ 11.2 million, mainly directed to the development of IT solutions (software), specially in the implementation of SAP and the development of the operational platform of the dental plans segment (Odonto Utilis).
  • 15. New Management Since April, 2009 BUs Since IPO Since December, 2009 Since IPO Since June, 2009 Since November, 2009 Corporate Structure Since July, 2009 Since July, 2009 Since February, 2010